AstraZeneca PLC AZN
$ 63.2
-0.94%
Annual report 2023
added 11-16-2024
AstraZeneca PLC Financial Ratios 2011-2024 | AZN
Annual Financial Ratios AstraZeneca PLC
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | 706.1 | 39.4 | 88.4 | 38.7 | 25.6 | 19.6 | 28.8 | 72.7 | 31.4 | 10.0 | 6.5 |
P/S |
- | - | 2.2 | 4.7 | 4.8 | 3.8 | 3.4 | 3.0 | 3.3 | 3.4 | 3.1 | 2.2 | 1.9 |
EPS |
- | - | 0.1 | 2.4 | 1.0 | 1.7 | 2.4 | 2.8 | 2.2 | - | - | - | - |
EV (Enterprise Value) |
56.1 B | 53.3 B | 141 B | 169 B | 159 B | 125 B | 120 B | 109 B | 123 B | 129 B | 113 B | 92.4 B | 94.5 B |
EBITDA per Share |
- | - | 0.74 | 1.98 | 1.12 | 1.34 | 1.45 | 1.45 | 1.28 | 0.918 | 1.53 | 3.27 | 4.81 |
EV/EBITDA |
76.5 | 38.8 | 82.0 | 68.5 | 44.0 | 22.0 | 27.8 | 40.6 | 21.2 | 7.9 | 5.1 | ||
PEG |
- | -369.38 | 3.0 | 15.36 | 37.98 | -3.17 | 0.82 | 0.22 | -1.39 | -0.53 | -0.31 | 0.21 | |
P/B |
- | - | 2.1 | 8.1 | 8.1 | 5.9 | 4.6 | 4.1 | 4.4 | 4.6 | 3.4 | 2.6 | 2.8 |
P/CF |
- | - | 13.6 | 26.3 | 39.7 | 31.9 | 21.5 | 37.4 | 152.0 | 20.8 | 15.0 | 27.0 | 10.0 |
ROE % |
- | - | - | 20.44 | 9.15 | 15.34 | 18.03 | 20.99 | 15.26 | 6.28 | 10.99 | 26.29 | 42.53 |
ROA % |
- | - | 0.11 | 4.79 | 2.18 | 3.55 | 4.74 | 5.60 | 4.70 | 2.10 | 4.57 | 11.76 | 18.90 |
ROCE % |
- | - | - | 11.12 | 6.76 | 7.64 | 7.83 | 7.56 | 6.92 | 5.10 | 9.23 | 20.56 | 28.41 |
Current Ratio |
1.6 | 1.6 | 1.6 | 1.3 | 1.3 | 1.3 | 1.4 | 0.9 | 1.1 | 1.0 | 1.3 | 1.4 | 1.5 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | 206.5 | 168.4 | 122.5 | 132.4 | 139.5 | 112.2 |
DPO |
- | - | - | - | - | - | - | 264.5 | 272.5 | 218.2 | 173.4 | 181.4 | 130.5 |
Operating Cycle |
- | - | - | - | - | - | - | 206.5 | 168.4 | 122.5 | 132.4 | 139.5 | 112.2 |
Cash Conversion Cycle |
- | - | - | - | - | - | - | -58.0 | -104.2 | -95.7 | -40.9 | -41.9 | -18.4 |
All numbers in USD currency
Quarterly Financial Ratios AstraZeneca PLC
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | 0.42 | - | - | - | 0.58 | - | - | - | 0.09 | - | - | - | 0.27 | - | - | - | 0.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | 0.86 | - | - | - | 0.98 | - | - | - | 0.38 | - | - | - | 0.6 | - | - | - | 0.73 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
- | - | 3.50 | 7.01 | 7.01 | 3.50 | 8.91 | 10.81 | 10.81 | 5.40 | 6.11 | 1.42 | 1.42 | 0.71 | 2.95 | 4.47 | 4.47 | 2.24 | 5.13 | 5.79 | 5.79 | 2.89 | 2.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
- | - | 0.75 | 1.49 | 1.49 | 0.75 | 1.98 | 2.46 | 2.46 | 1.23 | 1.40 | 0.35 | 0.35 | 0.17 | 0.69 | 1.04 | 1.04 | 0.52 | 1.20 | 1.37 | 1.37 | 0.68 | 0.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | 2.19 | 4.38 | 4.38 | 2.19 | 5.27 | 6.15 | 6.15 | 3.08 | 4.15 | 2.15 | 2.15 | 1.08 | 2.80 | 3.46 | 3.46 | 1.73 | 3.60 | 3.74 | 3.74 | 1.87 | 1.87 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | 1.6 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.4 | - | 1.3 | - | 1.4 | - | - | - | 1.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency